Lexeo Therapeutics Q3 EPS $(0.43) Misses $(0.33) Estimate

Benzinga · 2d ago
Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.33) by 30.3 percent. This is a 30.3 percent decrease over losses of $(0.33) per share from the same period last year.